Combined-modality Therapy for Locally Advanced Esophageal Cancer in Endemic Region of Turkey: A Single-Center Multimodal Experience

Creative Commons License

Basaran H., Arslan D., Ozdemir O., Turna M., Ozdemir Y., Karaca S., ...More

IRANIAN RED CRESCENT MEDICAL JOURNAL, vol.23, no.3, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 3
  • Publication Date: 2021
  • Doi Number: 10.32592/ircmj.2021.23.3.325
  • Journal Name: IRANIAN RED CRESCENT MEDICAL JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), CAB Abstracts, EMBASE, Veterinary Science Database
  • Keywords: Chemoradiotherapy, Esophageal cancer, Prognosis, Survival, PHASE-III TRIAL, RADIATION-THERAPY, RANDOMIZED-TRIAL, SURGERY, CHEMORADIOTHERAPY, ADENOCARCINOMA
  • Open Archive Collection: AVESIS Open Access Collection
  • Akdeniz University Affiliated: Yes

Abstract

Background: Esophageal cancer (EC) is known as the most common cancer around the world. The evidence supports that preoperative chemoradiotherapy (CRT) improves resectability and survival in locally advanced EC patients.